Xiaodong Cui

Prof. Xiaodong Cui


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in Polymers
Verified
Journal Article
Open access
PDF file
WLWenting Liang
Wenting Liang
YHYu Huang
Yu Huang
DLDongtao Lu
Dongtao Lu
XMXuewen Ma
Xuewen Ma
TGTao Gong
Tao Gong
SSShaomin Shuang
Shaomin Shuang
A multifunctional targeted drug delivery platform (CDHA–MGO) has been successfully constructed by grafting β-cyclodextrin–hyaluronic acid polymers (CDHA) to Fe3O4–graphene oxide (MGO). The obtained CDHA–MGO nanocomposite has good water-dispersibility, easy magnetic separation, high near-infrared (NIR) photothermal heating, and excellent biocompatibility. The β-cyclodextrin-hyaluronic acid polymers efficaciously enhance the doxorubicin (DOX) loading amount up to 485.43 mg·g−1. Meanwhile, the Fe3O4–graphene oxide provides a facile photothermal response mechanism to handle the NIR-triggered release of DOX in weak acidic solvent environments. Significantly, the DOX-loaded nanocomposite (DOX@CDHA–MGO) has displayed CD44 receptor-mediated active targeting recognition and chemo-photothermal synergistic therapy of hepatoma cells. These findings suggest that the as-prepared drug delivery platform would be of valuable potential for cancer-targeted photo-chemotherapy.

Verified
Journal Article
Open access
PDF file
JLJiao Li
Jiao Li
MSMin Sun
Min Sun
XCXiaodong Cui
Xiaodong Cui
CLChen Li
Chen Li
Alzheimer’s disease (AD) is a neurodegenerative disease with high morbidity and mortality, for which there is no available cure. Currently, it is generally believed that AD is a disease caused by multiple factors, such as amyloid-beta accumulation, tau protein hyperphosphorylation, oxidative stress, and inflammation. Multitarget prevention and treatment strategies for AD are recommended. Interestingly, naturally occurring dietary flavonoids, a class of polyphenols, have been reported to have multiple biological activities and anti-AD effects in several AD models owing to their antioxidative, anti-inflammatory, and anti-amyloidogenic properties. In this review, we summarize and discuss the existing multiple pathogenic factors of AD. Moreover, we further elaborate on the biological activities of natural flavonoids and their potential mode of action and targets in managing AD by presenting a wide range of experimental evidence. The gathered data indicate that flavonoids can be regarded as prophylactics to slow the advancement of AD or avert its onset. Different flavonoids have different activities and varying levels of activity. Further, this review summarizes the structure–activity relationship of flavonoids based on the existing literature and can provide guidance on the design and selection of flavonoids as anti-AD drugs.

1 November 2020 in Acta Biochimica et Biophysica Sinica
Verified
Journal Article
Open access
PDF file
ZZZhijuan Zhao
Zhijuan Zhao
XCXiaodong Cui
Xiaodong Cui
XMXiaoli Ma
Xiaoli Ma
ZWZhuanhua Wang
Zhuanhua Wang
The self-nanoemulsifying drug delivery system has shown many advantages in drug delivery. In this study, a self-nanoemulsifying drug delivery system of buckwheat flavonoids was prepared for enhancing its antioxidant activity and oral bioavailability. A nanoemulsion of buckwheat flavonoids was developed and characterized, and its antioxidant, in vitro release, and in vivo bioavailability were determined. The nanoemulsion was optimized by the central composite design response surface experiment, and its particle size, polymer dispersity index (PDI), zeta potential, morphology, encapsulation efficiency, and stability were evaluated. The antioxidant activity was tested by measuring its 2,2-diphenyl-1-picrylhydrazyl scavenging activity, hydroxyl radical scavenging activity, and superoxide anion scavenging ability. In vitro release of buckwheat flavonoids nanoemulsion showed a higher cumulative release than the suspension, and the release fitting model followed the Ritger–Peppas and Weibull models. The effective concentration of the nanoemulsion was evaluated in vivo using a Wistar rat model, and the area under the plasma concentration-time curve of the buckwheat flavonoids nanoemulsion was 2.2-fold higher than that of the buckwheat flavonoid suspension. The Cmax of the nanoemulsion was 2.6-fold greater than that of the suspension. These results indicate that the nanoemulsion is a promising oral drug delivery system that can improve the oral bioavailability to satisfy the clinical requirements.

26 August 2015 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
ZWZhuanhua Wang
Zhuanhua Wang
SLShanshan Li
Shanshan Li
RRRong Ren
Rong Ren
JLJiao Li
Jiao Li
XCXiaodong Cui
Xiaodong Cui

1 September 2016 in Experimental Gerontology
Verified
Journal Article
Closed access
ZWZhuanhua Wang
Zhuanhua Wang
XMXiaoli Ma
Xiaoli Ma
JLJiao Li
Jiao Li
XCXiaodong Cui
Xiaodong Cui

1 February 2020 in Journal of Functional Foods
Verified
Journal Article
Open access
XMXiaoli Ma
Xiaoli Ma
JLJiao Li
Jiao Li
XCXiaodong Cui
Xiaodong Cui
CLChen Li
Chen Li
ZWZhuanhua Wang
Zhuanhua Wang